0.9110
-0.0890
(-8.90%)
At close: January 10 at 4:26:20 PM GMT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-8,294.0000
-8,294.0000
-5,177.0000
-5,918.0000
-3,401.0000
Investing Cash Flow
-620.0000
-620.0000
1,251.0000
2,827.0000
4,580.0000
Financing Cash Flow
13,207.0000
13,207.0000
2,562.0000
-804.0000
-181.0000
End Cash Position
5,250.0000
5,250.0000
974.0000
2,175.0000
6,119.0000
Capital Expenditure
-716.0000
-716.0000
-901.0000
-3,089.0000
-457.0000
Issuance of Capital Stock
15,387.0000
15,387.0000
3,623.0000
--
--
Free Cash Flow
-9,010.0000
-9,010.0000
-6,078.0000
-9,007.0000
-3,858.0000
9/30/2020 - 12/6/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1K0.BE IGM Biosciences Inc. R
6.00
0.00%
LSRM.SG CEL-SCI Corp
0.3992
+13.67%
LSRM.MU CEL-SCI Corp
0.3628
-0.38%
1K0.F IGM Biosciences, Inc.
1.9000
-68.33%
LSRM.F CEL-SCI Corporation
0.3478
-0.11%
1K0.MU IGM Biosciences Inc
4.8000
-21.31%
LSRM.BE CEL-SCI Corp
0.3470
+0.17%
LSRM.DU CEL-SCI Corp
0.3846
+9.57%
APTA.L Aptamer Group PLC
0.3300
0.00%
SLNCF Silence Therapeutics plc
1.6350
0.00%